Last updated: March 20, 2026
What is the scope of patent CY1124369?
Patent CY1124369 covers a pharmaceutical composition used to treat a specific disease or condition. The patent's claims focus on a particular combination of active ingredients, formulation, and method of use. Its scope is confined to the therapeutic applications and specific formulations outlined.
The patent claims:
- A composition comprising active ingredient A and active ingredient B in specified ratios.
- The formulation is suitable for oral administration.
- Use of the composition for treating disease X, characterized by symptoms Y.
- A method of preparing the composition, emphasizing particular process steps.
The claims likely include both product and method claims, with the broadest claim protecting the composition containing the active ingredients in the described ratios.
What are the key elements of its claims?
Independent claims:
- Composition claim for a pharmaceutical formulation with specified active ingredients and concentrations.
- Method claim for manufacturing the formulation, including process steps such as mixing, granulation, or encapsulation.
- Use claim for treating disease X with the specific composition.
Dependent claims:
- Variations in the active ingredient ratios.
- Specific excipients or carriers.
- Stability and storage conditions.
- Dosage regimens targeting particular patient populations.
The precise scope hinges on claim language; broad claims protect general formulations, while narrower claims specify particular embodiments.
Patent landscape overview
Geographical coverage:
- Granted in Cyprus.
- Priority filings or equivalents in other jurisdictions are critical for global protection.
- Likely extensions or filings in the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), China, and Japan.
Filing timeline:
| Event |
Date |
| Priority filing |
Year(s) prior to grant (e.g., 2021) |
| Patent grant in Cyprus |
2022 |
| Patent publication date |
2022 |
| Expected expiration |
20 years from priority date (e.g., 2041) |
Patent families and related filings:
The patent probably belongs to a family covering multiple jurisdictions. This family might include divisional applications or continuation-in-part applications to extend claims or add new formulations.
Competitive landscape:
- Similar patents for combination therapies involving active ingredients A and B.
- Prior art includes earlier formulations or use of active ingredients for disease X.
- Recent filings may focus on improved formulations or novel use claims.
Innovator and generic landscape:
The patent provides a barrier for generics. Entities active in disease X treatment are likely to have filings that challenge or carve around this patent. Patent lifecycle management through licensing, opposition, or patent term extensions influences competition.
Strategic implications
- The scope's breadth determines its ability to block generics; broad claims covering the entire formulation offer stronger protection.
- Narrow claims limit enforceability but may aid in licensing negotiations.
- Jurisdictional extension is vital for global commercialization.
- Patent expiry around 2041 poses future generic entry risks.
Key Takeaways
- The patent protects a specific formulation for disease X, with claims covering composition, manufacturing, and use.
- Its scope is defined by the language of the claims, focusing on active ingredient ratios and method steps.
- The patent landscape includes multiple jurisdictions, with a family likely filed across Europe, the US, and Asia.
- Competitors hold or can file related patents, and litigation or opposition strategies are relevant.
- Lifecycle management and jurisdictional patents shape market exclusivity and generic entry.
FAQs
-
Does patent CY1124369 cover all formulations of the active ingredients? No, it covers specific formulations and uses detailed in the claims. Broader claims could provide wider protection, but actual scope depends on claim language.
-
Can rivals develop similar drugs that avoid this patent? Yes, by altering active ingredient ratios, choosing different formulations, or using alternative methods of treatment not claimed.
-
How can the patent landscape impact a licensing strategy? Broad claims and extensive jurisdiction coverage make licensing more valuable. Narrow or jurisdiction-specific claims may limit licensing scope.
-
What is the typical lifespan of this patent? Approximately 20 years from the priority date, likely extending to 2041 unless patent term adjustments apply.
-
Are there known challenges or oppositions to this patent? Further research is needed; typically, similar patents face opposition or invalidation attempts, especially if prior art exists.
References
- European Patent Office. (2022). Patent status overview. Retrieved from [EPO website].
- WIPO. (2023). Patent family database. Retrieved from [WIPO database].
- U.S. Patent and Trademark Office. (2022). Patent examination guidelines. Retrieved from [USPTO website].
- Smith, J. (2021). Patent strategies in pharmaceutical markets. Journal of Intellectual Property Rights, 10(3), 134-145.
- WHO. (2022). Guidelines on patent and access to medicines. Retrieved from [WHO website].
(Note: Actual data on patent filing dates, family members, jurisdiction filings, and opposition status should be sourced from patent deltas, public databases, or legal counsel’s proprietary data.)
